JPH09169655A - Powder for external use for dermatic ulcer - Google Patents

Powder for external use for dermatic ulcer

Info

Publication number
JPH09169655A
JPH09169655A JP33314595A JP33314595A JPH09169655A JP H09169655 A JPH09169655 A JP H09169655A JP 33314595 A JP33314595 A JP 33314595A JP 33314595 A JP33314595 A JP 33314595A JP H09169655 A JPH09169655 A JP H09169655A
Authority
JP
Japan
Prior art keywords
powder
weight
water
iodine
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP33314595A
Other languages
Japanese (ja)
Other versions
JP2953649B2 (en
Inventor
Toshibumi Kanbara
俊文 神原
Yoshio Mizushima
良男 水島
Akihiro Iida
昭宏 飯田
Mineo Hata
峯男 秦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IWAKI SEIYAKU KK
Original Assignee
IWAKI SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IWAKI SEIYAKU KK filed Critical IWAKI SEIYAKU KK
Priority to JP33314595A priority Critical patent/JP2953649B2/en
Publication of JPH09169655A publication Critical patent/JPH09169655A/en
Application granted granted Critical
Publication of JP2953649B2 publication Critical patent/JP2953649B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide the subject powder composed of a sugar, a water-swelling cellulose compound, a binder and an iodophor, having excellent fluidity and water-absorptivity, easily absorbing and removing the exudate from wound surface and giving low stimulation to the wound. SOLUTION: This powder is composed of (A) 60-80wt.% of a sugar (preferably sucrose), (B) 20-40wt.% of a water-swelling cellulose compound (preferably a hydroxypropylcellulose having low substitution degree), (C) 0.5-3.0wt.% of a binder (preferably a hydroxypropylcellulose) and (D) 0.5-10wt.% of a iodophor (preferably povidone iodine). The powder can be produced preferably by mixing the component A with the component B, adding a solution produced by dissolving the component C in a lower alkanol (e.g. methanol) to the mixture, kneading, drying and granulating the product and mixing with the component D.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、皮膚潰瘍用外用散
剤に関し、さらに詳しくは糖およびヨードホールを有効
成分とする皮膚潰瘍用外用散剤に関する。
TECHNICAL FIELD The present invention relates to an external powder for skin ulcer, and more particularly to an external powder for skin ulcer containing sugar and iodine as active ingredients.

【0002】[0002]

【従来の技術】ヨードホールは強力な殺菌力を有し、し
かも刺激性や組織障害が低いことから、手指の消毒や手
術部位の消毒などに使用されており、また蜂蜜、糖蜜、
蔗糖などの糖は火傷や創傷の治療に古くから使用されて
いる。
2. Description of the Related Art Iodophor has a strong bactericidal activity, and since it has low irritation and tissue damage, it is used for disinfecting fingers and surgical sites, and honey, molasses,
Sugar such as sucrose has long been used to treat burns and wounds.

【0003】ヨードの殺菌作用、糖の肉芽形成促進作用
を期待して、ヨードホールと糖を主成分とする軟膏が大
学病院内で調剤され使用されている。このような製剤の
改良されたものとして、糖、ポビドンヨード、水および
pHを調整する緩衝剤からなる軟膏剤が知られている
(特公平1−32210)。この製剤においては、ポビ
ドンヨードの含量が一定でない、ポビドンヨードと糖と
の練合が困難である、製剤が二層に分離する、有効成分
が分解して薬効が低下する等の従来の軟膏剤の欠点が克
服されており、広く市販されている。しかしながら、こ
の軟膏剤は、固く延びが悪く、創面に塗布しにくいこと
が指摘されており、また創面からの滲出液の吸収が十分
でないという難点を有している。
With the expectation of the bactericidal action of iodine and the granulation formation promoting action of sugar, an ointment mainly containing iodine and sugar is prepared and used in university hospitals. As an improved product of such a preparation, an ointment comprising sugar, povidone iodine, water and a buffer for adjusting pH is known (Japanese Patent Publication No. 1-23210). In this formulation, the content of povidone iodine is not constant, the mixing of povidone iodine and sugar is difficult, the formulation is separated into two layers, the active ingredient is decomposed and the medicinal effect is lowered, and the drawbacks of conventional ointments. Has been overcome and is widely marketed. However, it has been pointed out that this ointment is hard and has poor spreadability and is difficult to apply to the wound surface, and has a drawback that absorption of exudate from the wound surface is not sufficient.

【0004】創面への適用を容易にすべく、ヨードホー
ルを溶かした溶液を微細な糖にスプレーしたヨードホー
ル含有の自由流動性の創傷用散剤(特開昭61−215
324)が提案されている。また、溶液形態のヨードホ
ール製剤が取り扱いに難点のあることから、水溶性ヨー
ドホールと尿素または糖アルコール(特にマンニトー
ル)からなる顆粒または粉末形態のヨードホール組成物
(特開昭63−77805)が提案されている。これら
のヨードホール製剤は均質性と流動性に優れ、創面に自
由に散布することができ、取り扱いも容易であるという
利点を有している。しかしながら、いずれの製剤も水溶
性であるため、創面に適用した際に滲出液の吸収が、必
ずしも十分でない。
To facilitate application to the wound surface, a free-flowing wound powder containing iodine, which is obtained by spraying a fine sugar with a solution in which iodine is dissolved (JP-A-61-215).
324) has been proposed. In addition, since the iodine preparation in the form of a solution is difficult to handle, an iodine composition in the form of a granule or a powder comprising water-soluble iodine and urea or sugar alcohol (particularly mannitol) (Japanese Patent Laid-Open No. 63-77805) has been proposed. Proposed. These iodine-hole preparations have the advantages that they are excellent in homogeneity and fluidity, can be freely sprayed on the wound surface, and are easy to handle. However, since all the formulations are water-soluble, the absorption of exudate when applied to the wound surface is not always sufficient.

【0005】[0005]

【発明が解決しようとする課題】本発明は、流動性に優
れ、創面に自由に散布することができ、取り扱いも容易
であるという従来の散剤の利点を保持しつつ、更にpH
調整を行うことなく刺激性を少なくし、又創面の滲出液
を吸収し、かつ除去し易い形態を有する皮膚潰瘍用外用
散剤を提供せんとするものである。
DISCLOSURE OF THE INVENTION The present invention retains the advantages of conventional powders that are excellent in fluidity, can be freely sprayed on the wound surface, and are easy to handle, and further have a pH value.
It is intended to provide an external powder for skin ulcer that has a form that reduces irritation without adjustment, absorbs exudate on the wound surface, and is easy to remove.

【0006】[0006]

【課題を解決するための手段】本発明は、糖60〜80
重量%、水膨潤性セルロース化合物20〜40重量%、
結合剤0.5〜3.0重量%およびヨードホール0.5〜
10重量%からなる皮膚潰瘍用外用散剤よりなる。
The present invention provides sugars 60-80.
% By weight, 20 to 40% by weight of water-swellable cellulose compound,
Binder 0.5-3.0% by weight and iodine hole 0.5-
It consists of an external powder for skin ulcer consisting of 10% by weight.

【0007】さらに本発明は、糖と水膨潤性セルロース
化合物とを混合し、該混合物に低級アルカノールに結合
剤を溶解した溶液を加えて練合し、練合物を乾燥後、整
粒した物にヨードホールを加えて混合することからなる
上記皮膚潰瘍用外用散剤の製造方法からなる。
Further, according to the present invention, a sugar and a water-swellable cellulose compound are mixed, a solution in which a binder is dissolved in a lower alkanol is added to the mixture, and the mixture is kneaded. The kneaded product is dried and then sized. A method for producing the external powder for skin ulcer, which comprises adding iodine hole to the mixture and mixing.

【0008】本発明における糖としては、肉芽形成促進
作用および静菌作用を有する糖が使用され、その例とし
ては、蔗糖、グルコース、デキストロース、果糖、乳糖
などがあげられる。蔗糖、特に日本薬局方の白糖、精製
白糖が好ましい。配合量は肉芽形成促進作用および静菌
作用を発揮できる量であり、全組成物の60〜80重量
%である。
As the sugar in the present invention, a sugar having a granulation promoting action and a bacteriostatic action is used, and examples thereof include sucrose, glucose, dextrose, fructose, lactose and the like. Sucrose, particularly sucrose and purified sucrose of the Japanese Pharmacopoeia, are preferred. The compounding amount is an amount capable of exerting a granulation formation promoting action and a bacteriostatic action, and is 60 to 80% by weight of the total composition.

【0009】本発明で使用される水膨潤性セルロース化
合物とは、水に不溶性であって、水を加えたときに水を
吸収して膨潤するセルロース化合物をいい、その例とし
て、低置換度ヒドロキシプロピルセルロース、カルボキ
シメチルエチルセルロース、カルメロース、カルメロー
スカルシウム、クロスカルメロースナトリウム、結晶セ
ルロース、酢酸セルロースなどがあげられる。これらの
セルロース化合物は吸水性に優れているので、本発明の
散剤を創面に適用したときに滲出液を吸収することがで
きる。特に好適なセルロース化合物は低置換度ヒドロキ
シプロピルセルロースである。このものはセルロースの
低置換度ヒドロキシプロピルエーテルであって、乾燥し
たものを定量するとき、ヒドロキシプロポキシル基5.
0〜16.0%を含む。低置換度ヒドロキシプロピルセ
ルロースなどの水膨潤性セルロース化合物は、通常固形
製剤の結合剤、崩壊剤として全組成物の2.0〜5.0重
量%用いられるが、本発明においては散剤としての流動
性、創面からの吸水能および膨潤による剥離性を高める
ため、全組成物の20〜40重量%用いられる。
The water-swellable cellulose compound used in the present invention is a cellulose compound which is insoluble in water and absorbs water to swell when added with water, for example, a low-substituted hydroxy compound. Examples include propyl cellulose, carboxymethyl ethyl cellulose, carmellose, carmellose calcium, croscarmellose sodium, crystalline cellulose, and cellulose acetate. Since these cellulose compounds are excellent in water absorption, they can absorb exudate when the powder of the present invention is applied to the wound surface. A particularly preferred cellulose compound is low substituted hydroxypropyl cellulose. This is a low-substituted hydroxypropyl ether of cellulose, which has a hydroxypropoxy group of 5.
Including 0 to 16.0%. A water-swellable cellulose compound such as low-substituted hydroxypropyl cellulose is usually used as a binder and a disintegrant in a solid preparation in an amount of 2.0 to 5.0% by weight of the total composition, but in the present invention, it is used as a powder. 20 to 40% by weight of the total composition is used in order to improve the properties, the water absorbing ability from the wound surface and the peelability due to swelling.

【0010】結合剤としては、低級アルカノールに易溶
性のヒドロキシプロピルセルロースなど通常外用散剤に
使用されているものが用いられる。使用量は全組成物の
0.5〜3.0重量%である。
As the binder, those commonly used in external powders such as hydroxypropyl cellulose which is easily soluble in lower alkanols are used. The amount used is 0.5-3.0% by weight of the total composition.

【0011】本発明で用いられるヨードホールは、ヨウ
素と有機ポリマー例えばポリデキストロースまたはポリ
ビニルピロリドン(ポビドン)の生理学的に許容され得
る複合体である。特にヨウ素とポビドンとの複合体であ
るポビドンヨードが好適に使用される。使用量は全組成
物の0.5〜10重量%、好ましくは1.0〜5.0重量
%である。
The iodophor used in the present invention is a physiologically acceptable complex of iodine and an organic polymer such as polydextrose or polyvinylpyrrolidone (povidone). Particularly, povidone iodine, which is a complex of iodine and povidone, is preferably used. The amount used is 0.5 to 10% by weight of the total composition, preferably 1.0 to 5.0% by weight.

【0012】本発明の外用散剤は、糖と水膨潤性のセル
ロース化合物とを混合し、該混合物に適量の低級アルカ
ノールに結合剤を溶解した溶液を加えて練合し、練合物
を乾燥後、整粒した物にヨードホールを加えて混合する
ことによって好適に製造される。上記の混合、練合およ
び造粒の各工程は外用散剤を製造する場合の常法にした
がって実施され得る。低級アルカノールとしては、メタ
ノール、エタノール、イソプロパノールなどが用いられ
るが、エタノールが最も好ましい。上記の各成分は日本
薬局方あるいは日本薬局方外医薬品成分規格に記載のも
のを使用するのが望ましい。
The powder for external use of the present invention is prepared by mixing sugar and a water-swelling cellulose compound, kneading the mixture with a solution of a binder dissolved in an appropriate amount of a lower alkanol, and kneading the mixture. It is preferably produced by adding iodine holes to the sized product and mixing them. The above-mentioned steps of mixing, kneading and granulation can be carried out according to a conventional method for producing a powder for external use. As the lower alkanol, methanol, ethanol, isopropanol and the like are used, and ethanol is most preferable. It is desirable to use those listed in the Japanese Pharmacopoeia or the Japanese Pharmacopoeia Standards for Pharmaceutical Ingredients.

【0013】[0013]

【実施例】次に実施例および試験例を示して本発明をさ
らに具体的に説明する。 実施例1 ポビドンヨード 3.0重量% 精製白糖 70.0重量% 低置換度ヒドロキシプロピルセルロース 26.0重量% ヒドロキシプロピルセルロース 1.0重量% 撹拌混合機によりとを混合、回転流動しながら日本
薬局方エタノール適量にを溶かした溶液を加えて練合
・造粒する。これを乾燥し、40メッシュで整粒する。
整粒したものにを加えて混合し外用散剤とする。実施
例1で得た外用散剤は流動性を示し、水分を吸収すると
弾力のある塊となり、皮膚面を刺激することなく剥離容
易となり、水で容易に洗い流すことができる。上記散剤
を40℃で4カ月間密封アルミ袋に保存した場合の外観
を観察した。また糖の含量を高速液体クロマトグラフ法
で、有効ヨウ素の含量を滴定法によりそれぞれ測定し、
残存率を算出した。その結果を表1に示す。表1の結果
から明らかなように、本願発明の散剤は経時的に安定で
ある。
EXAMPLES Next, the present invention will be described more specifically by showing Examples and Test Examples. Example 1 Povidone-iodine 3.0% by weight Purified sucrose 70.0% by weight Low-substituted hydroxypropylcellulose 26.0% by weight Hydroxypropylcellulose 1.0% by weight Mixing with a stirrer while rotating and flowing, Japanese Pharmacopoeia Knead and granulate by adding a solution prepared by dissolving an appropriate amount of ethanol. This is dried and sized with 40 mesh.
Add to the sized powder and mix to make a powder for external use. The external use powder obtained in Example 1 exhibits fluidity, and when it absorbs water, it becomes a lump with elasticity, is easily peeled off without irritating the skin surface, and can be easily washed off with water. The appearance of the above powder when stored in a sealed aluminum bag at 40 ° C. for 4 months was observed. The content of sugar is measured by high performance liquid chromatography, and the content of available iodine is measured by titration method.
The residual rate was calculated. Table 1 shows the results. As is clear from the results in Table 1, the powder of the present invention is stable over time.

【0014】[0014]

【表1】 2 カ 月 4 カ 月 実施例1散剤 糖残存率(%) 99.1 99.4 有効ヨウ素残存率(%) 94.5 92.3 外 観 変化なし 変化なし[Table 1] 2 months 4 months Example 1 Powder Remaining rate of sugar (%) 99.1 99.4 Remaining rate of available iodine (%) 94.5 92.3 No change in external appearance No change

【0015】比較例1 ポビドンヨード 3.0重量% 精製白糖 70.0重量% D−マンニトール 26.0重量% ヒドロキシプロピルセルロース 1.0重量% 実施例1の低置換度ヒドロキシプロピルセルロースの
代わりに、公知処方例(特開昭63−77805号)の
糖アルコールであるマンニトールを使用し、実施例1の
製法で外用散剤を調製した。実施例1〜4の散剤と比較
例1の散剤及び本発明で使用する水膨潤性セルロースに
ついて下記の吸水試験を行った。 〔吸水試験法〕Water Absorption Apparatus〔伊東明彦
ら:「病院薬学」Vol.20,No.1,p.43(1994)〕を用い、
試料2gの吸液により電子天秤上のビーカーの液量が減
少し、電子天秤の示す重量が変化するのを経時的に測定
し、その値を読み取り飽和時の量を吸水量とした。その
結果を表2に示す。表2から実施例1〜4の散剤が比較
例1の散剤に比較して優れた吸収能を有することが明ら
かである。特に実施例1の散剤は比較例1の散剤に比べ
7倍(実施例4の散剤は約10倍)の吸水能を有する。
また本発明で使用する水膨潤性セルロースが優れた吸水
能を有することが明らかである。
Comparative Example 1 Povidone iodine 3.0% by weight Purified sucrose 70.0% by weight D-mannitol 26.0% by weight Hydroxypropylcellulose 1.0% by weight Instead of the low-substituted hydroxypropylcellulose of Example 1, a known compound was used. A powder for external use was prepared by the production method of Example 1 using mannitol, which is a sugar alcohol of the formulation example (JP-A-63-77805). The following water absorption test was conducted on the powders of Examples 1 to 4, the powder of Comparative Example 1 and the water-swellable cellulose used in the present invention. [Water absorption test method] Water Absorption Apparatus [Akihiko Ito et al .: "Hospital Pharmacy" Vol. 20, No. 1, p. 43 (1994)]
It was measured with time that the liquid amount of the beaker on the electronic balance decreased due to the liquid absorption of 2 g of the sample and the weight indicated by the electronic balance changed, and the value was read and the amount at saturation was taken as the water absorption amount. Table 2 shows the results. It is clear from Table 2 that the powders of Examples 1 to 4 have superior absorption ability as compared with the powder of Comparative Example 1. In particular, the powder of Example 1 has a water absorption capacity 7 times that of the powder of Comparative Example 1 (about 10 times that of the powder of Example 4).
Further, it is clear that the water-swellable cellulose used in the present invention has an excellent water absorbing ability.

【0016】[0016]

【表2】 品 名 吸水量(g数) 実施例1散剤 2.68 実施例2散剤 1.68 実施例3散剤 1.29 実施例4散剤 3.59 比較例1散剤 0.36 D−マンニトール 0.81 低置換度ヒドロキシプロピルセルロース 11.97 カルメロース 4.60 カルメロースカルシウム 9.82 クロスカルメロースナトリウム 13.06 結晶セルロース 5.27 酢酸セルロース 5.65 (温度25.5℃,湿度49%)Table 2 Product name Water absorption (g) Example 1 powder 2.68 Example 2 powder 1.68 Example 3 powder 1.29 Example 4 powder 3.59 Comparative example 1 powder 0.36 D-mannitol 0.81 Low-substituted hydroxypropyl cellulose 11.97 Carmellose 4.60 Carmellose calcium 9.82 Croscarmellose sodium 13.06 Crystalline cellulose 5.27 Cellulose acetate 5.65 (Temperature 25.5 ° C, Humidity 49%)

【0017】実施例2 ポビドンヨード 3.0重量% 精製白糖 65.0重量% カルメロース 35.0重量% ヒドロキシプロピルセルロース 2.0重量% 以上の組成からなる外用散剤を実施例1と同様に製造し
た。
Example 2 Povidone-iodine 3.0% by weight Purified sucrose 65.0% by weight Carmellose 35.0% by weight Hydroxypropylcellulose 2.0% by weight An external use powder having the above composition was prepared in the same manner as in Example 1.

【0018】実施例3 ポビドンヨード 3.0重量% 精製白糖 60.0重量% 結晶セルロース 30.0重量% ヒドロキシプロピルセルロース 2.0重量% 以上の組成からなる外用散剤を実施例1と同様に製造し
た。
Example 3 Povidone-iodine 3.0% by weight Purified sucrose 60.0% by weight Crystalline cellulose 30.0% by weight Hydroxypropylcellulose 2.0% by weight An external powder having the above composition was prepared in the same manner as in Example 1. .

【0019】実施例4 ポビドンヨード 3.0重量% 精製白糖 70.0重量% クロスカルメロースナトリウム 26.0重量% ヒドロキシプロピルセルロース 1.0重量% 以上の組成からなる外用散剤を実施例1と同様に製造し
た。
Example 4 Povidone-iodine 3.0% by weight Purified sucrose 70.0% by weight Croscarmellose sodium 26.0% by weight Hydroxypropylcellulose 1.0% by weight As in Example 1, an external use powder having the above composition was used. Manufactured.

【0020】[0020]

【発明の効果】本発明によれば、流動性および吸水性に
優れたポビドンヨード含有の皮膚潰瘍用外用散剤が得ら
れる。本発明の製剤は流動性のある散剤であるため、取
り扱いが容易であり、創面に隈無く密着するよう塗布す
ることができる。また、吸水性に優れているので、創面
からの滲出液を吸収することができ、創面の乾燥化、細
菌感染の抑制、肉芽形成の促進をもたらすことができ
る。さらに、本発明によれば、使用後の創面からの除去
が容易な皮膚潰瘍用外用散剤が得られる。本発明の散剤
は滲出液を吸収して弾力のある塊となり、創面から剥離
し易くなるので除去が容易となり、水で簡単に洗い流す
ことができる。本発明の外用散剤は、pHを調整しなく
ても経時的に安定であり、また皮膚への刺激性が少な
い。このような利点を有することから、本発明のポビド
ンヨード皮膚潰瘍用外用散剤は、褥蒼、熱傷のような皮
膚潰瘍治療に好適に使用することができる。
INDUSTRIAL APPLICABILITY According to the present invention, an external powder for skin ulcer containing povidone iodine having excellent fluidity and water absorbability can be obtained. Since the preparation of the present invention is a flowable powder, it is easy to handle and can be applied so as to be intimately adhered to the wound surface. Further, since it is excellent in water absorption, it can absorb the exudate from the wound surface, which can lead to dryness of the wound surface, suppression of bacterial infection, and promotion of granulation. Furthermore, according to the present invention, an external powder for skin ulcer that can be easily removed from the wound surface after use is obtained. The powder of the present invention absorbs the exudate to form an elastic mass and is easily separated from the wound surface, so that the powder can be easily removed, and can be easily washed off with water. The external use powder of the present invention is stable over time without adjusting the pH, and has little skin irritation. Due to these advantages, the povidone-iodine external powder for skin ulcers of the present invention can be suitably used for the treatment of skin ulcers such as pimples and burns.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 //(A61K 31/79 A61K 9/14 U 33:18 31:70) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location // (A61K 31/79 A61K 9/14 U 33:18 31:70)

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 糖60〜80重量%、水膨潤性セルロー
ス化合物20〜40重量%、結合剤0.5〜3.0重量%
およびヨードホール0.5〜10重量%からなる皮膚潰
瘍用外用散剤。
1. Sugar 60 to 80% by weight, water-swellable cellulose compound 20 to 40% by weight, binder 0.5 to 3.0% by weight.
And an external powder for skin ulcer, which comprises 0.5 to 10% by weight of iodine.
【請求項2】 糖が蔗糖である請求項1記載の皮膚潰瘍
用外用散剤。
2. The external powder for skin ulcer according to claim 1, wherein the sugar is sucrose.
【請求項3】 水膨潤性セルロース化合物が低置換度ヒ
ドロキシプロピルセルロースである請求項1または2記
載の皮膚潰瘍用外用散剤。
3. The external powder for skin ulcer according to claim 1, wherein the water-swellable cellulose compound is low-substituted hydroxypropyl cellulose.
【請求項4】 結合剤がヒドロキシプロピルセルロース
である請求項1乃至3のいずれかの項に記載の皮膚潰瘍
用外用散剤。
4. The external powder for skin ulcer according to claim 1, wherein the binder is hydroxypropyl cellulose.
【請求項5】 ヨードホールがポビドンヨードである請
求項1乃至4記載の皮膚潰瘍用外用散剤。
5. The external powder for skin ulcers according to claim 1, wherein the iodine hole is povidone iodine.
【請求項6】 糖と水膨潤性セルロース化合物とを混合
し、該混合物に低級アルカノールに結合剤を溶解した溶
液を加えて練合し、練合物を乾燥後、整粒した物にヨー
ドホールを加えて混合することからなる請求項1に記載
の皮膚潰瘍用外用散剤の製造方法。
6. A sugar and a water-swellable cellulose compound are mixed, a solution of a binder dissolved in a lower alkanol is added to the mixture, and the mixture is kneaded. After drying the kneaded product, iodine is added to the sized product. The method for producing an external powder for skin ulcer according to claim 1, which comprises adding and mixing.
JP33314595A 1995-12-21 1995-12-21 Topical powder for skin ulcer Expired - Lifetime JP2953649B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP33314595A JP2953649B2 (en) 1995-12-21 1995-12-21 Topical powder for skin ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33314595A JP2953649B2 (en) 1995-12-21 1995-12-21 Topical powder for skin ulcer

Publications (2)

Publication Number Publication Date
JPH09169655A true JPH09169655A (en) 1997-06-30
JP2953649B2 JP2953649B2 (en) 1999-09-27

Family

ID=18262804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33314595A Expired - Lifetime JP2953649B2 (en) 1995-12-21 1995-12-21 Topical powder for skin ulcer

Country Status (1)

Country Link
JP (1) JP2953649B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224937A1 (en) * 1999-10-22 2002-07-24 Nippi, Incorporated Stable preparations for treating bedsore, skin ulcer and wound
WO2004011032A1 (en) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. External preparation
US8323693B2 (en) 2002-03-14 2012-12-04 Medrx Co., Ltd. External preparation for wounds
CN104069070A (en) * 2014-06-27 2014-10-01 深圳市格易通消毒药械科技有限公司 Povidone-iodine powder with effective sterilization and disinfection effects and preparation method thereof
ITBA20130047A1 (en) * 2013-06-07 2014-12-08 Simone Tenerelli COMPOSITION FOR THE PROTECTION AND HEALING OF DECUBITUS, VASCULAR AND DIABETIC ULCERS.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957918A1 (en) 1999-11-25 2001-06-13 Ulrich Doht Disinfectant cleaner for cleaning and care and process for its manufacture

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224937A1 (en) * 1999-10-22 2002-07-24 Nippi, Incorporated Stable preparations for treating bedsore, skin ulcer and wound
EP1224937A4 (en) * 1999-10-22 2007-03-07 Nippi Inc Stable preparations for treating bedsore, skin ulcer and wound
US8323693B2 (en) 2002-03-14 2012-12-04 Medrx Co., Ltd. External preparation for wounds
WO2004011032A1 (en) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. External preparation
ITBA20130047A1 (en) * 2013-06-07 2014-12-08 Simone Tenerelli COMPOSITION FOR THE PROTECTION AND HEALING OF DECUBITUS, VASCULAR AND DIABETIC ULCERS.
CN104069070A (en) * 2014-06-27 2014-10-01 深圳市格易通消毒药械科技有限公司 Povidone-iodine powder with effective sterilization and disinfection effects and preparation method thereof

Also Published As

Publication number Publication date
JP2953649B2 (en) 1999-09-27

Similar Documents

Publication Publication Date Title
JP3583166B2 (en) Powder preparation for damaged skin repair
EP0258761B1 (en) Wound-healing preparations
US5102666A (en) Calcium polycarbophil controlled release composition and method
US4981875A (en) Medicaments for the region of the oral cavity
US5211958A (en) Pharmaceutical composition and process for its preparation
JPH0567612B2 (en)
CN1814279A (en) Regenerated human alkali fiber-cell growth factor gel former and preparing method
JP3064417B2 (en) Controlled release formulations and methods
CN106178111B (en) A kind of gel filled preparation of rhinology Thermo-sensitive and preparation method thereof and the application in nasal surgery
US20110104279A1 (en) Healing powder and method of use thereof
JPH09169655A (en) Powder for external use for dermatic ulcer
US20110021455A1 (en) Sterilised sucralfate gel
JPH0745406B2 (en) Method for producing free-flowing and homogeneous wound powder containing iodine
JP2000038342A (en) Pharmaceutical preparation for restoring bedsore and damaged skin
JP2798287B2 (en) Anti-inflammatory agent
JPS6310731A (en) Stable reparative pharmaceutical for damaged skin
CN113713113B (en) Composition for treating oral mucosa diseases and preparation method thereof
CN107595819B (en) A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof
JP3472442B2 (en) Formulation for repairing damaged skin
CA1334933C (en) Pharmaceutical composition and process for its preparation
JPH10203963A (en) Orally administrable pharmaceutical composition containing microbicidal material and mucosa-adhesive material
KR100978905B1 (en) External medicine for wounds
RU2536266C2 (en) Cream for medicinal purposes, made with application of framycetin sulfate and chitosan
JPH11100323A (en) Pharmaceutical preparation for external use
EP0436015B1 (en) Rectally administered pharmaceutical preparation

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090716

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090716

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100716

Year of fee payment: 11